Commentary

25+ Years of Migraine


 

Suggested Reading

Bigal ME, Lipton RB. Clinical course in migraine: conceptualizing migraine transformation. Neurology. 2008;71(11):848-855.

Deen M, Correnti E, Kamm K, et al. Blocking CGRP in migraine patients – a review of pros and cons. J Headache Pain. 2017;18(1):96.

Dodick DW. Migraine. Lancet. 2018;391(10127):1315-1330.

Färkkilä M, Diener HC, Géraud G, et al. Efficacy and tolerability of lasmiditan, an oral 5-HT(1F) receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study. Lancet Neurology. 2012;11(5):405-413.

Goadsby PJ, Reuter U, Hallström Y, et al. A controlled trial of erenumab for episodic migraine. N Engl J Med. 2017;377(22):2123-2132.

Humphrey PP. The discovery and development of the triptans, a major therapeutic breakthrough. Headache. 2008;48(5):685-687.

Puledda F, Goadsby PJ. An update on non-pharmacological neuromodulation for the acute and preventive treatment of migraine. Headache. 2017;57(4):685-691.

Silberstein SD, Dodick DW, Bigal ME, et al. Fremanezumab for the preventive treatment of chronic migraine. N Engl J Med. 2017;377(22):2113-2122.

Wietecha LA, Kuca B, Case MG, et al. Phase 3 study (SPARTAN) of lasmiditan compared to placebo for acute treatment of migraine. Cephalalgia. 2017;37 (suppl 1):367-68 (abstr).

Pages

Recommended Reading

MRI Techniques Could Help Distinguish Between MS and Migraine
MDedge Neurology
Does Migraine Transiently Open the Blood–Brain Barrier?
MDedge Neurology
Erenumab May Control Migraines When Other Preventives Have Failed
MDedge Neurology
Noninvasive Neurostimulator Shows Efficacy in Episodic Migraine
MDedge Neurology
FDA approves Aimovig for migraine prevention
MDedge Neurology
FDA Updates
MDedge Neurology
How Common Are Comorbidities in Chronic Versus Episodic Migraine?
MDedge Neurology
Ubrogepant May Treat Acute Migraine Attacks Effectively
MDedge Neurology
Eptinezumab May Reduce Migraine Frequency in Patients With Chronic and Episodic Migraine
MDedge Neurology
Fremanezumab May Be an Effective Preventive Treatment for Chronic Migraine
MDedge Neurology